Adaptyv
Announced 26 Aug 2026$40.0M · Series A · Manufacturing · Switzerland
Proteins are the most advanced nanotechnology we know of. At Adaptyv Bio we’re building a next-gen protein foundry to allow you to synthesize and test any protein you design.
“Lausanne-based Adaptyv raises €34.35 million Series A to build the automated lab for agentic biology - EU-Startups Before you continue EN English United States Deutsch English Español Français Italiano All languages Afrikaans azərbaycan bosanski català Čeština Cymraeg Dansk Deutsch eesti English United Kingdom Español España Español Latinoamérica e”
5 more sources tracked. Read the full press release and reporter coverage.
Sign up to read →Investors: Highland Europe.